Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Chemotherapy and Pharmacology|August 7, 2012
Safety and feasibility of adjuvant chemotherapy with S-1 for Korean patients with curatively resected advanced gastric cancerJae Ho Jeong, Min-Hee Ryu, Baek-Yeol Ryoo, et al.Cancer Chemotherapy and Pharmacology|August 8, 2013
A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinomaInkeun Park, Min-Hee Ryu, Yoon Hee Choi, et al.Journal of Cancer|June 21, 2021
RNF43 and PWWP2B inhibit cancer cell proliferation and are predictive or prognostic biomarker for FDA-approved drugs in patients with advanced gastric cancerSung-Hwa Sohn, Hee Jung Sul, Bohyun Kim, et al.Cancer Chemotherapy and Pharmacology|September 16, 2016
A dose-finding study for oxaliplatin, irinotecan, and S-1 (OIS) in patients with metastatic or recurrent gastrointestinal cancerBoram Han, Joo Young Jung, Hyeong Su Kim, et al.Scandinavian Journal of Gastroenterology|June 23, 2017
Is it beneficial to perform surgical resection in elderly patients more than 80 years old with advanced gastric cancer?Jin Woo Choo, Yeonmi Ju, Hyun Lim, et al.Gastrointestinal Endoscopy|September 6, 2011
Clinical impact of EUS-guided Trucut biopsy results on decision making for patients with gastric subepithelial tumors ≥ 2 cm in diameterJeong Hoon Lee, Kee Don Choi, Mi-Young Kim, et al.Journal of Clinical Gastroenterology|May 28, 2011
Predictors of recurrence after resection of small gastric gastrointestinal stromal tumors of 5 cm or lessMi-Young Kim, Young Soo Park, Kee Don Choi, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 27, 2018
Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11Hyeong Su Kim, Min-Hee Ryu, Dae Young Zang, et al.EMBO Reports|May 18, 2022
PWWP2B promotes DNA end resection and homologous recombinationMin Kyung Ju, Joo Rak Lee, Yeonsong Choi, et al.Pageof 2